Lymphoma Coalition Research

Lymphoma Coalition has used the results from the Global Patient Survey on Lymphomas and CLL (GPS) to conduct and publish its own research on the patient experience. It is imperative the issues raised globally by patients through the biennial survey are conveyed to the medical and research communities to improve care moving forward.

View all of LC's Research

Browse Resources

Over 4,000 articles on scientific advances in research, treatments & patient care

Find CLINICAL TRIALS & TREATMENTS near you

Ukraine Conflict Response

Lymphoma Coalition pledges our support to all in the lymphoma community affected by what is unfolding in Ukraine. LC has built a collaboration amongst Member organisations and other partners and allies in Ukraine and surrounding countries to provide tangible help.

►Допомога для пацієнтів з лімфомою та ХЛЛ,що покидають Україну

►Assistance for patients with lymphoma & CLL leaving Ukraine

►Assistance for clinicians in Ukraine

Chronic Lymphocytic Leukaemia (CLL)

The 2022 CLL Subtype Report: is now available!

The focus of this report is to:

► Provide a current understanding of CLL

► Explain the diagnosis and pre-treatment process

► Outline CLL treatment options and protocols, including:

► Therapy access in Lymphoma Coalition (LC) member countries

► Clinical trial access in LC member countries

► Highlight Covid-19-related considerations for patients with CLL

► Explore the experience of patients with CLL

Lymphoma Coalition Europe

The 2022 Lymphoma Care in Europe is now available!

The focus of this report is to:

► Examine the burden of lymphoma (disease burden and economic impact) in Europe.

► Spotlight the experience of patients with lymphoma and why this experience matters for healthcare decision-making.

► Identify and make recommendations for future lymphoma advocacy initiatives in Europe.

Q&As with Members of...

The InterLymph Consortium is more formally known as the International Consortium of Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic Studies. Created in 2001 by the International Agency for Research on Cancer (IARC) and the National Cancer Institute (USA), the Consortium is an international group of scientists who undertake research projects that pool data across studies to better understand lymphoma risk factors and causes. Lymphoma Coalition is proud to partner with the InterLymph Consortium in this important research. Lymphoma Coalition interviewed epidemiologists from the InterLymph Consortium to find out about their research in lymphomas.